Therapeutic Potential of Cherry Phenolics in Managing Inflammation and Lipid Metabolism in Diabetes and Obesity

Authors

  • Tausif Ahmad
  • Aaima Farooq
  • Sehrish Kanwal
  • Shaheer Khan
  • Wania Adan
  • Rida Maqsood
  • Smeea Fatima
  • Areeba Sanaullah

DOI:

https://doi.org/10.53555/j5zk3364

Keywords:

Cherries, Diabetes, inflammation, lipid metabolism, non-anthocyanin phenolics, obesity

Abstract

This study investigates the potential therapeutic effects of non-anthocyanin phenolics derived from cherries (Prunus avium L.) in addressing inflammatory and metabolic disturbances associated with diabetes and obesity. Using a diabetic obese mouse model, the study explores the impact of cherry phenolics on inflammatory cytokines, liver lipid profiles, and gene expression related to inflammation and lipid metabolism. The results demonstrate significant reductions in serum inflammatory cytokines, liver triglycerides, total cholesterol, and non-esterified fatty acids, accompanied by downregulating critical genes involved in inflammation and lipogenesis. These findings suggest that cherry phenolics possess antiinflammatory and lipid-lowering properties, highlighting their potential as therapeutic agents for managing diabetes and obesity-related complications.

Author Biographies

  • Tausif Ahmad

    PhD Scholar, Department of Agricultural Engineering and Food Sciences, Shandong University of Science and Technology, China

  • Aaima Farooq

    Dietitian and Nutritionist, Job Leading Nutrition Department, Chaudhary Muhammad Akram Teaching and Research Hospital, Lahore, Pakistan

  • Sehrish Kanwal

    Master Student, Karakoram International University, Pakistan 

  • Shaheer Khan

    Bachelor Student, University of Lahore, Lahore, Pakistan 

  • Wania Adan

    MPhil Scholar, University of Lahore, Lahore, Pakistan

  • Rida Maqsood

    MPhil Scholar, University of Lahore, Lahore, Pakistan 

  • Smeea Fatima

    Lecturer, Rashid Latif Khan University, Lahore, Pakistan 

  • Areeba Sanaullah

    Lecturer, ARID University, Burewala Campus, Pakistan 

References

Smith, S. R., Lovejoy, J. C., Greenway, F., Ryan, D., de Jonge, L., de la Bretonne, J., Volaufova, J., & Bray, G. A. (2020). Contributions of total body fat, abdominal subcutaneous adipose tissue, and visceral adipose tissue to the metabolic complications of obesity. Metabolism, 50(4), 425–435.

World Health Organization (WHO). (2020). Obesity and overweight.

Zhao, H., Liu, B., Zhang, W., Cao, J., & Jiang, W. (2019). Enhancement of quality and antioxidant metabolism of sweet cherry fruit by near-freezing temperature storage. Postharvest Biology and Technology, pp. 147, 113–122.

Donath, M. Y., & Shoelson, S. E. (2011). Type 2 diabetes as an inflammatory disease. *Nature Reviews Immunology*, 11(2), 98-107.

Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. *Nature*, 444(7121), 860-867.

Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002). SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. *Journal of Clinical Investigation*, 109(9), 1125-1131.

Kelley, D. S., Rasooly, R., Jacob, R. A., Kader, A. A., & Mackey, B. E. (2006). Consumption of Bing sweet cherries lowers circulating concentrations of inflammation markers in healthy men and women. *The Journal of Nutrition*, 136(4), 981-986.

Kim, D. O., Heo, H. J., Kim, Y. J., Yang, H. S., & Lee, C. Y. (2005). Sweet and sour cherry phenolics and their protective effects on neuronal cells. *Journal of Agricultural and Food Chemistry*, 53(26), 9921-9927.

Seeram, N. P., Momin, R. A., Nair, M. G., & Bourquin, L. D. (2001). Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. *Phytomedicine*, 8(5), 362-369.

Wang, H., Nair, M. G., Strasburg, G. M., Chang, Y. C., Booren, A. M., Gray, J. I., & DeWitt, D. L. (1999). Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. *Journal of Natural Products*, 62(2), 294-296.

Yki-Järvinen, H. (2014). Nonalcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. *Lancet Diabetes Endocrinol*, 2(11), 901-910.

Downloads

Published

2024-09-24

How to Cite

Tausif Ahmad, Aaima Farooq, Sehrish Kanwal, Shaheer Khan, Wania Adan, Rida Maqsood, Smeea Fatima, & Areeba Sanaullah. (2024). Therapeutic Potential of Cherry Phenolics in Managing Inflammation and Lipid Metabolism in Diabetes and Obesity. Journal of Population Therapeutics and Clinical Pharmacology, 31(9), 3230-3241. https://doi.org/10.53555/j5zk3364
More Citation Formats

Issue

Section

Articles

How to Cite

Tausif Ahmad, Aaima Farooq, Sehrish Kanwal, Shaheer Khan, Wania Adan, Rida Maqsood, Smeea Fatima, & Areeba Sanaullah. (2024). Therapeutic Potential of Cherry Phenolics in Managing Inflammation and Lipid Metabolism in Diabetes and Obesity. Journal of Population Therapeutics and Clinical Pharmacology, 31(9), 3230-3241. https://doi.org/10.53555/j5zk3364

Most read articles by the same author(s)